Non-Traditional Non-Immunological Risk Factors for Kidney Allograft Loss—Opinion

Rates of late allograft loss have improved slowly in the last decades. Well described traditional risk factors that influence allograft survival include cardiovascular events, rejection, infections and post-transplant neoplasia. Here, we critically evaluate the influence of several non-immunological, non-traditional risk factors and describe their impact on allograft survival and cardiovascular health of kidney transplant recipients. We assessed the following risk factors: arterial stiffness, persistent arteriovenous access, mineral bone disease, immunosuppressive drugs residual levels variability, hypomagnesemia, glomerular pathological alterations not included in Banff criteria, persistent inflammation and metabolic acidosis.

[1]  R. Wüthrich,et al.  Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial , 2023, The Lancet.

[2]  Byron H. Smith,et al.  Changes in Glomerular Volume, Sclerosis, and Ischemia at 5 Years after Kidney Transplantation: Incidence and Correlation with Late Graft Failure , 2022, Journal of the American Society of Nephrology : JASN.

[3]  Vignesh Viswanathan,et al.  Long-Term Immunological Outcomes of Early Subclinical Inflammation on Surveillance Kidney Allograft Biopsies. , 2022, Kidney international.

[4]  A. Sharif,et al.  Survival for waitlisted kidney failure patients receiving transplantation versus remaining on waiting list: systematic review and meta-analysis , 2022, BMJ.

[5]  Bhanu K. Patibandla,et al.  Impact of Post-Transplantation Hypomagnesemia on Long-Term Graft and Patient Survival after Transplantation , 2022, Kidney and Blood Pressure Research.

[6]  B. De Moor,et al.  Forecasting of Patient-Specific Kidney Transplant Function With a Sequence-to-Sequence Deep Learning Model , 2021, JAMA network open.

[7]  M. Haas,et al.  30 years of the International Banff Classification for Allograft Pathology: The Past, Present and Future of Kidney Transplant Diagnostics. , 2021, Kidney international.

[8]  S. Parajuli,et al.  New Approaches to Cardiovascular Disease and Its Management in Kidney Transplant Recipients , 2021, Transplantation.

[9]  J. Gubensek,et al.  A national cohort study on hemodialysis arteriovenous fistulas after kidney transplantation - long-term patency, use and complications , 2021, BMC Nephrology.

[10]  X. Jouven,et al.  Dynamic prediction of renal survival among deeply phenotyped kidney transplant recipients using artificial intelligence: an observational, international, multicohort study. , 2021, The Lancet. Digital health.

[11]  Vasileios A. Tatsis,et al.  Longitudinal Assessment of Electrolyte Disorders in a Cohort of Chronic Stable Kidney Transplant Recipients. , 2021, Transplantation proceedings.

[12]  A. Israni,et al.  Long-Term Survival after Kidney Transplantation. , 2021, The New England journal of medicine.

[13]  R. Bloom,et al.  Beyond the Biopsy: Monitoring Immune Status in Kidney Recipients. , 2021, Clinical journal of the American Society of Nephrology : CJASN.

[14]  T. Nickolas,et al.  Bone and Mineral Disease in Kidney Transplant Recipients. , 2021, Clinical journal of the American Society of Nephrology : CJASN.

[15]  B. Astor,et al.  Post‐kidney transplant serum magnesium exhibits a U‐shaped association with subsequent mortality: an observational cohort study , 2021, Transplant international : official journal of the European Society for Organ Transplantation.

[16]  Ponticelli Claudio,et al.  The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation. , 2021, Kidney international.

[17]  K. Budde,et al.  Exploring the Complexity of Death-Censored Kidney Allograft Failure , 2021, Journal of the American Society of Nephrology : JASN.

[18]  Andras T. Deak,et al.  Hypomagnesemia Is a Risk Factor for Infections after Kidney Transplantation: A Retrospective Cohort Analysis , 2021, Nutrients.

[19]  S. Mohan,et al.  Managing Patients with Failing Kidney Allograft , 2021, Clinical journal of the American Society of Nephrology : CJASN.

[20]  X. Jouven,et al.  Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes. , 2020, Journal of the American Society of Nephrology : JASN.

[21]  Bhanu K. Patibandla,et al.  Posttransplantation Hypomagnesemia as a Predictor of Better Graft Function after Transplantation , 2020, Kidney and Blood Pressure Research.

[22]  N. Mohebbi,et al.  Causes and Consequences of Metabolic Acidosis in Patients after Kidney Transplantation , 2020, Kidney and Blood Pressure Research.

[23]  A. Więcek,et al.  Is Metabolic Acidosis a Novel Risk Factor for a Long-Term Graft Survival in Patients after Kidney Transplantation? , 2020, Kidney and Blood Pressure Research.

[24]  X. Jouven,et al.  Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation. , 2020, Kidney international.

[25]  J. Cooper,et al.  Tacrolimus Intra-Patient Variability, Time in Therapeutic Range, and Risk of De Novo Donor-Specific Antibodies. , 2020, Transplantation.

[26]  B. Kasiske,et al.  Inflammation in areas of fibrosis: The DeKAF prospective cohort , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[27]  C. Miles,et al.  Electrolyte Disorders in Kidney Transplantation. , 2020, Clinical journal of the American Society of Nephrology : CJASN.

[28]  M. Naesens,et al.  The Causes of Kidney Allograft Failure: More Than Alloimmunity. A Viewpoint Article. , 2020 .

[29]  M. Naesens,et al.  The causes of kidney allograft failure: more than allo-immunity. A viewpoint paper. , 2020, Transplantation.

[30]  Jianghua Chen,et al.  To ligate or not to ligate: a meta-analysis of cardiac effects and allograft function following arteriovenous fistula closure in renal transplant recipients. , 2020, Annals of vascular surgery.

[31]  Olivier Aubert,et al.  Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study , 2019, BMJ.

[32]  D. Segev,et al.  Fractures and Subsequent Graft Loss and Mortality among Older Kidney Transplant Recipients , 2019, Journal of the American Geriatrics Society.

[33]  U. Kunzendorf,et al.  Effect of Sodium Bicarbonate in Kidney Transplant Recipients With Chronic Metabolic Acidosis , 2019, Transplantation direct.

[34]  S. Navaneethan,et al.  Effects of Treatment of Metabolic Acidosis in CKD: A Systematic Review and Meta-Analysis. , 2019, Clinical journal of the American Society of Nephrology : CJASN.

[35]  S. Bangalore,et al.  Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies. , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  D. Mikhailidis,et al.  Arterial Stiffness in the Heart Disease of CKD. , 2019, Journal of the American Society of Nephrology : JASN.

[37]  K. Hemming,et al.  PreImplantation Trial of Histopathology In renal Allografts (PITHIA): a stepped-wedge cluster randomised controlled trial protocol , 2019, BMJ Open.

[38]  J. Subra,et al.  Serum Magnesium after Kidney Transplantation: A Systematic Review , 2018, Nutrients.

[39]  M. Tapolyai,et al.  Inflammatory Markers and Outcomes in Kidney Transplant Recipients , 2017, Transplantation.

[40]  M. Briet,et al.  Reversal of Arterial Stiffness and Maladaptative Arterial Remodeling After Kidney Transplantation , 2017, Journal of the American Heart Association.

[41]  A. Hartmann,et al.  Early introduction of oral paricalcitol in renal transplant recipients. An open‐label randomized study , 2017, Transplant international : official journal of the European Society for Organ Transplantation.

[42]  D. Wheeler,et al.  KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) , 2017, Kidney international supplements.

[43]  Y. Kim,et al.  Metabolic Acidosis and Long-Term Clinical Outcomes in Kidney Transplant Recipients. , 2017, Journal of the American Society of Nephrology : JASN.

[44]  R. Lechler,et al.  Strategies for long-term preservation of kidney graft function , 2017, The Lancet.

[45]  M. Arias,et al.  Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development , 2016, Transplantation.

[46]  Meltem Seziş Demirci,et al.  The effect of hypercalcemia on allograft calcification after kidney transplantation , 2016, International Urology and Nephrology.

[47]  J. Torras,et al.  A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism. , 2016, Journal of the American Society of Nephrology : JASN.

[48]  S. Kim,et al.  Hypomagnesemia and the Risk of New-Onset Diabetes Mellitus after Kidney Transplantation. , 2016, Journal of the American Society of Nephrology : JASN.

[49]  M. Angelini,et al.  Vitamin D in Kidney Transplant Recipients: Mechanisms and Therapy , 2016, American Journal of Nephrology.

[50]  S. Vettoretti,et al.  Metabolic acidosis in renal transplantation: neglected but of potential clinical relevance. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[51]  S. Erickson,et al.  Hypomagnesemia linked to new-onset diabetes mellitus after kidney transplantation: A systematic review and meta-analysis , 2016, Endocrine research.

[52]  O. Franco,et al.  Arterial Stiffness and Decline in Kidney Function. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[53]  Morten Wang Fagerland,et al.  Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients , 2015, Transplantation.

[54]  B. Rutkowski,et al.  A Randomized Study Evaluating Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients With Persistent Hyperparathyroidism , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[55]  E. Lerut,et al.  The Histology of Kidney Transplant Failure: A Long-Term Follow-Up Study , 2014, Transplantation.

[56]  C. Jacquelinet,et al.  Similar patient survival following kidney allograft failure compared with non-transplanted patients. , 2014, Kidney international.

[57]  S. Kim,et al.  Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure. , 2014, Kidney international.

[58]  K. Kalantar-Zadeh,et al.  Association of pre-kidney transplant markers of mineral and bone disorder with post-transplant outcomes. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[59]  C. Ahn,et al.  Clinical manifestations of hypercalcemia and hypophosphatemia after kidney transplantation. , 2012, Transplantation proceedings.

[60]  K. Aksu,et al.  Inflammation-induced thrombosis: mechanisms, disease associations and management. , 2012, Current pharmaceutical design.

[61]  M. Jadoul,et al.  Aortic Stiffness and Central Wave Reflections Predict Outcome in Renal Transplant Recipients , 2011, Hypertension.

[62]  D. Kuypers,et al.  Diagnosis and prevention of chronic kidney allograft loss , 2011, The Lancet.

[63]  D. Webb,et al.  Selective Endothelin-A Receptor Antagonism Reduces Proteinuria, Blood Pressure, and Arterial Stiffness in Chronic Proteinuric Kidney Disease , 2011, Hypertension.

[64]  W. Weimar,et al.  High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[65]  S. Sengul,et al.  Renal tubular acidosis after kidney transplantation--incidence, risk factors and clinical implications. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[66]  W. Zidek,et al.  Impaired Renal Allograft Function is Associated with Increased Arterial Stiffness in Renal Transplant Recipients , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[67]  J. Blacher,et al.  Aortic Stiffness, Living Donors, and Renal Transplantation , 2006, Hypertension.

[68]  C. Kendziorski,et al.  Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[69]  D. Urbauer,et al.  Low intraindividual variability of cyclosporin A exposure reduces chronic rejection incidence and health care costs. , 2000, Journal of the American Society of Nephrology : JASN.

[70]  M. M. Joosten,et al.  Associations of 25(OH) and 1,25(OH)2 vitamin D with long-term outcomes in stable renal transplant recipients. , 2015, The Journal of clinical endocrinology and metabolism.

[71]  J. Cruzado,et al.  Arterial stiffness in kidney transplantation: a single center case-control study comparing belatacept versus calcineurin inhibitor immunosuppressive based regimen. , 2015, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.